Journal article
Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho
The FASEB journal, Vol.31(8), pp.3574-3586
08/2017
DOI: 10.1096/fj.201700043R
PMCID: PMC5503716
PMID: 28442546
Abstract
Soluble Klotho (sKlotho) is the shed ectodomain of antiaging membrane Klotho that contains 2 extracellular domains KL1 and KL2, each of which shares sequence homology to glycosyl hydrolases. sKlotho elicits pleiotropic cellular responses with a poorly understood mechanism of action. Notably, in injury settings, sKlotho confers cardiac and renal protection by down-regulating calcium-permeable transient receptor potential canonical type isoform 6 (TRPC6) channels in cardiomyocytes and glomerular podocytes. Inhibition of PI3K-dependent exocytosis of TRPC6 is thought to be the underlying mechanism, and recent studies showed that sKlotho interacts with α2-3-sialyllactose-containing gangliosides enriched in lipid rafts to inhibit raft-dependent PI3K signaling. However, the structural basis for binding and recognition of α2-3-sialyllactose by sKlotho is unknown. Using homology modeling followed by docking, we identified key protein residues in the KL1 domain that are likely involved in binding sialyllactose. Functional experiments based on the ability of Klotho to down-regulate TRPC6 channel activity confirm the importance of these residues. Furthermore, KL1 domain binds α2-3-sialyllactose, down-regulates TRPC6 channels, and exerts protection against stress-induced cardiac hypertrophy in mice. Our results support the notion that sialogangliosides and lipid rafts are membrane receptors for sKlotho and that the KL1 domain is sufficient for the tested biologic activities. These findings can help guide the design of a simpler Klotho mimetic.-Wright, J. D., An, S.-W., Xie, J., Yoon, J., Nischan, N., Kohler, J. J., Oliver, N., Lim, C., Huang, C.-L. Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho.
Details
- Title: Subtitle
- Modeled structural basis for the recognition of α2-3-sialyllactose by soluble Klotho
- Creators
- Jon D Wright - Institute of Biomedical Sciences, Academia Sinica, Taipei, TaiwanSung-Wan An - Department of Internal Medicine, University of Texas Southwestern Medical Center, Texas, USAJian Xie - Department of Internal Medicine, University of Texas Southwestern Medical Center, Texas, USAJoonho Yoon - Department of Internal Medicine, University of Texas Southwestern Medical Center, Texas, USANicole Nischan - Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USAJennifer J Kohler - Department of Biochemistry, University of Texas Southwestern Medical Center, Dallas, Texas, USANoelynn Oliver - Cardiometabolic Disease Research, Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, Connecticut, USACarmay Lim - Department of Chemistry, National Tsing Hua University, HsinChu, TaiwanChou-Long Huang - Department of Internal Medicine, University of Texas Southwestern Medical Center, Texas, USA; chou-long.huang@utsouthwestern.edu
- Resource Type
- Journal article
- Publication Details
- The FASEB journal, Vol.31(8), pp.3574-3586
- DOI
- 10.1096/fj.201700043R
- PMID
- 28442546
- PMCID
- PMC5503716
- NLM abbreviation
- FASEB J
- ISSN
- 0892-6638
- eISSN
- 1530-6860
- Grant note
- R01 DK100605 / NIDDK NIH HHS R01 DK109887 / NIDDK NIH HHS
- Language
- English
- Date published
- 08/2017
- Academic Unit
- Nephrology; Internal Medicine
- Record Identifier
- 9984094382502771
Metrics
18 Record Views